Close Menu

NEW YORK – BioMérieux today reported that its second quarter revenues rose approximately 10 percent year over year. The firm attributed the growth to a robust performance in molecular biology.

For the three months ended June 30, BioMérieux reported revenues of €643.5 million ($709.6 million), up from €582.2 million in the prior-year period. Organic growth, at constant exchange rates and scope of consolidation, was about 7 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.